/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

West Pharmaceutical Services Inc Share Price Today: Live Updates & Key Insights

West Pharmaceutical Services Inc share price today is $231.09, up -3.01%. The stock opened at $237.26 against the previous close of $238.25, with an intraday high of $240.17 and low of $231.05.

West Pharmaceutical Services Inc Share Price Chart

style
pb-0

West Pharmaceutical Services Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

West Pharmaceutical Services Inc Share Price Performance

$231.09 -0.0301(-3.01%) WST at 13 Mar 2026 03:55 PM Medical Instruments & Supplies
Lowest Today 231.05
Highest Today 240.17
Today’s Open 237.26
Prev. Close 238.25
52 Week High 321.79
52 Week Low 186.77
Day’s Range: Low 231.05 High 240.17
52-Week Range: Low 186.77 High 321.79
1 day return -
1 Week return -6.0
1 month return -7.74
3 month return -14.99
6 month return -10.32
1 year return +3.28
3 year return -28.09
5 year return -16.22
10 year return -

West Pharmaceutical Services Inc Institutional Holdings

Vanguard Group Inc 13.24

BlackRock Inc 8.96

State Street Corp 4.45

Bank of New York Mellon Corp 4.03

Artisan Partners Limited Partnership 3.96

Brown Advisory Holdings Inc 3.47

Vanguard Total Stock Mkt Idx Inv 3.15

Geode Capital Management, LLC 2.58

Vanguard 500 Index Investor 2.55

Generation Investment Management LLP 2.17

Vanguard Mid Cap Index Institutional 2.16

Morgan Stanley - Brokerage Accounts 2.05

Van Eck Associates Corporation 1.98

Apg All Pensions Group 1.96

Longview Partners (Guernsey) Limited 1.57

Kayne Anderson Rudnick Investment Management LLC 1.44

Vanguard Growth Index Investor 1.39

NORGES BANK 1.37

Franklin Resources Inc 1.34

iShares Core S&P 500 ETF 1.27

Fidelity 500 Index 1.27

UBS Asset Mgmt Americas Inc 1.23

Amvescap Plc. 1.22

State Street® SPDR® S&P 500® ETF 1.19

Franklin Rising Dividends Fund A 1.09

Northern Trust Corp 1.03

Citadel Advisors Llc 1.01

T. Rowe Price Mid-Cap Growth 0.98

T. Rowe Price Investment Management,Inc. 0.97

Findlay Park American I USD Dist 0.93

ProShares S&P 500 Dividend Aristocrats 0.91

VanEck Morningstar Wide Moat 0.89

Invesco S&P 500® Equal Weight ETF 0.89

VanEck Morningstar Wide Moat ETF 0.87

Vanguard Mid-Cap Growth ETF 0.84

State Street®HlthCrSelSectSPDR®ETF 0.74

T. Rowe Price US Mid-Cap Growth Equity 0.72

Brown Advisory Sustainable Growth I 0.61

Vanguard Institutional Index I 0.57

Vanguard Dividend Appreciation ETF 0.55

West Pharmaceutical Services Inc Market Status

Strong Buy: 10

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

West Pharmaceutical Services Inc Fundamentals

Market Cap 17159.12 M

PB Ratio 5.4027

PE Ratio 35.0884

Enterprise Value 16688.92 M

Total Assets 4270.00 M

Volume 913666

West Pharmaceutical Services Inc Company Financials

Annual Revenue FY25:3073700000 3073.7M, FY24:2893200000 2893.2M, FY23:2926500000 2926.5M, FY22:2886900000 2886.9M, FY21:2831600000 2831.6M

Annual Profit FY25:1103300000 1103.3M, FY24:998500000 998.5M, FY23:1113100000 1113.1M, FY22:1136200000 1136.2M, FY21:1175800000 1175.8M

Annual Net worth FY25:493700000 493.7M, FY24:492700000 492.7M, FY23:559400000 559.4M, FY22:585900000 585.9M, FY21:661800000 661.8M

Quarterly Revenue Q4/2025:805000000 805.0M, Q3/2025:804300000 804.3M, Q2/2025:766200000 766.2M, Q1/2025:698200000 698.2M, Q4/2024:748800000 748.8M

Quarterly Profit Q4/2025:303900000 303.9M, Q3/2025:293500000 293.5M, Q2/2025:273200000 273.2M, Q1/2025:232700000 232.7M, Q4/2024:273600000 273.6M

Quarterly Net worth Q4/2025:132100000 132.1M, Q3/2025:140000000 140.0M, Q2/2025:131800000 131.8M, Q1/2025:89800000 89.8M, Q4/2024:130100000 130.1M

About West Pharmaceutical Services Inc & investment objective

Company Information West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Organisation Medical Instruments & Supplies

Employees 10800

Industry Medical Instruments & Supplies

CEO Mr. Eric M. Green

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow